Velu PP et al. |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung. |
2016 |
Scott Med J |
pmid:27872397
|
Noh HM et al. |
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice. |
2016 |
Korean J Gastroenterol |
pmid:27871162
|
Yazdanbakhsh AR et al. |
Reduction of non-Betalactam Antibiotics COD by Combined Coagulation and Advanced Oxidation Processes. |
2016 |
Water Environ. Res. |
pmid:28661328
|
Fan W et al. |
An unusual case of folliculitis spinulosa decalvans. |
2016 |
Cutis |
pmid:27814407
|
Miftahussurur M et al. |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. |
2016 |
BMC Microbiol. |
pmid:27809767
|
Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Zycinska K et al. |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. |
2016 |
Adv. Exp. Med. Biol. |
pmid:27620311
|
Bax HI et al. |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883697
|
Hirata Y et al. |
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen. |
2016 |
Int. J. Infect. Dis. |
pmid:27590563
|
Sancak S et al. |
Intestinal blood flow by Doppler ultrasound: the impact of clarithromycin treatment for feeding intolerance in preterm neonates. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26135789
|
Uehara H et al. |
Comparison of the Anti-angiogenic and Anti-inflammatory Effects of Two Antibiotics: Clarithromycin Versus Moxifloxacin. |
2016 |
Curr. Eye Res. |
pmid:26125497
|
Zhou L et al. |
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial. |
2016 |
Helicobacter |
pmid:26104022
|
Ohe M et al. |
A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. |
2016 |
Kaohsiung J. Med. Sci. |
pmid:27638410
|
Phaw NA and Tsai HH |
Eosinophilic gastroenteritis: a challenge to diagnose and treat. |
2016 |
BMJ Case Rep |
pmid:27613263
|
Plate A |
[Not Available]. |
2016 |
Praxis (Bern 1994) |
pmid:27606919
|
Huh CW et al. |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. |
2016 |
PLoS ONE |
pmid:27588679
|
Watanabe M et al. |
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal. |
2016 |
Int J Pharm |
pmid:27553780
|
Nagashima A et al. |
Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27550358
|
Couture G et al. |
[Second case of serum sickness-like reaction to claritrhomycin]. |
2016 |
Presse Med |
pmid:27542759
|
Bugli F et al. |
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. |
2016 |
Biotechnol. Prog. |
pmid:27535356
|
Shichijo S et al. |
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice. |
2016 |
J Dig Dis |
pmid:27534444
|
Cosme A et al. |
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance. |
2016 |
Helicobacter |
pmid:25982426
|
Morimoto K et al. |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. |
2016 |
Ann Am Thorac Soc |
pmid:27513168
|
Lotfipour F et al. |
Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori. |
2016 |
Drug Res (Stuttg) |
pmid:25919643
|
Zemali N et al. |
Helicobacter pylori resistance to clarithromycin in Reunion Island. |
2016 |
Med Mal Infect |
pmid:27427280
|
Ozeki K et al. |
Association of Hay Fever with the Failure of Helicobacter pylori Primary Eradication. |
2016 |
Intern. Med. |
pmid:27374672
|
Campillo A et al. |
[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection]. |
2016 |
Med Clin (Barc) |
pmid:27374029
|
Khashei R et al. |
High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. |
2016 |
APMIS |
pmid:27357065
|
Alarcón-Millán J et al. |
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. |
2016 |
Infect. Genet. Evol. |
pmid:27355861
|
Khonche A et al. |
Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial. |
2016 |
Drug Res (Stuttg) |
pmid:27351245
|
Büchsel M et al. |
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia. |
2016 |
Diagn. Microbiol. Infect. Dis. |
pmid:27342785
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
De Francesco V et al. |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication. |
2016 |
J Gastrointestin Liver Dis |
pmid:27308644
|
Miyaki A et al. |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. |
2016 |
Minerva Gastroenterol Dietol |
pmid:27304198
|
Okano Y et al. |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report. |
2016 |
BMC Pulm Med |
pmid:27287608
|
Garcia de Carvalho NF et al. |
Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group. |
2016 |
J. Clin. Lab. Anal. |
pmid:27169515
|
Schuster S et al. |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27161641
|
Akram FE et al. |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). |
2016 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:27530257
|
Oberhofer E |
[Quadruple therapy is more effective against H. pylori]. |
2016 |
MMW Fortschr Med |
pmid:27155683
|
Mayor S |
Short term increase in neuropsychiatric events is seen with H pylori treatment containing clarithromycin. |
2016 |
BMJ |
pmid:27143325
|
Shokri-Shirvani J et al. |
Letter: global emergence of Helicobacter pylori antibiotic resistance - unanswered questions. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137738
|
Wong AY et al. |
Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin. |
2016 |
JAMA Intern Med |
pmid:27136661
|
Zollner-Schwetz I et al. |
Primary resistance of Helicobacter pylori is still low in Southern Austria. |
2016 |
Int. J. Med. Microbiol. |
pmid:27134190
|
Georgopoulos SD et al. |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. |
2016 |
Eur. J. Intern. Med. |
pmid:27134145
|
Kim JS et al. |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. |
2016 |
Gut Liver |
pmid:27114421
|
Manniello MD et al. |
Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt. |
2016 |
Eur J Pharm Biopharm |
pmid:27106605
|
Fallone CA et al. |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. |
2016 |
Gastroenterology |
pmid:27102658
|
Bilgilier C et al. |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients. |
2016 |
Ann. Hematol. |
pmid:27091350
|
Root AA et al. |
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs. |
2016 |
Br J Clin Pharmacol |
pmid:27090996
|
Kazama I et al. |
Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells. |
2016 |
Chemotherapy |
pmid:27088971
|
Huynh VA et al. |
[Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]. |
2016 |
Ann Dermatol Venereol |
pmid:27080820
|
EmiralioÄŸlu N et al. |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome. |
2016 |
J. Trop. Pediatr. |
pmid:27080471
|
Radzikowska E et al. |
Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. |
2016 |
Adv. Exp. Med. Biol. |
pmid:26987326
|
Wu DC et al. |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection. |
2016 |
Medicine (Baltimore) |
pmid:26986096
|
Swaminathan A et al. |
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications. |
2016 |
Int. J. Tuberc. Lung Dis. |
pmid:26970156
|
Wong IC |
Author's reply to Blake. |
2016 |
BMJ |
pmid:26957514
|
Todo K et al. |
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female. |
2016 |
Ann. Hematol. |
pmid:26957356
|
Iyer G and Alexander GC |
Editorialists' reply to Blake. |
2016 |
BMJ |
pmid:26957321
|
Blake Z |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction. |
2016 |
BMJ |
pmid:26955978
|
Seyama S et al. |
Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26953210
|
Ji Z et al. |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China. |
2016 |
Medicine (Baltimore) |
pmid:26937912
|
Murakami K et al. |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. |
2016 |
Gut |
pmid:26935876
|
Park JY et al. |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. |
2016 |
Dig. Dis. Sci. |
pmid:26923948
|
Guirao-Arrabal E et al. |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. |
2016 |
Rev Esp Quimioter |
pmid:26888341
|
Friedman ND et al. |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883709
|
Chua CS et al. |
The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial. |
2016 |
Int J Food Sci Nutr |
pmid:26883189
|
Trac MH et al. |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. |
2016 |
CMAJ |
pmid:26903359
|
Tebruegge M et al. |
Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center. |
2016 |
PLoS ONE |
pmid:26812154
|
Fralick M et al. |
Bleeding associated with coadministration of rivaroxaban and clarithromycin. |
2016 |
CMAJ |
pmid:26811362
|
Berlin S et al. |
Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals. |
2016 |
Mol. Pharm. |
pmid:26808255
|
Sun H et al. |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. |
2016 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:26792053
|
Miglietta F et al. |
A rare case of Saprochaete capitata fungemia in a critical ill patient without hematologic and oncological disorders. |
2016 |
Rev Esp Quimioter |
pmid:26785226
|
Mukai S et al. |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. |
2016 |
Int. J. Oncol. |
pmid:26718641
|
Raymond J et al. |
Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. |
2016 |
Scand. J. Gastroenterol. |
pmid:26784882
|
Kefeli A et al. |
Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial. |
2016 |
Bosn J Basic Med Sci |
pmid:26773183
|
Iyer G and Alexander GC |
Cardiovascular risks associated with clarithromycin. |
2016 |
BMJ |
pmid:26769796
|
Wong AY et al. |
Cardiovascular outcomes associated with use of clarithromycin: population based study. |
2016 |
BMJ |
pmid:26768836
|
Hirama T et al. |
PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates. |
2016 |
J. Clin. Microbiol. |
pmid:26739154
|
Radheshi E et al. |
Postmortem diagnosis of anaphylaxis in presence of decompositional changes. |
2016 |
J Forensic Leg Med |
pmid:26735898
|
Hassan ST et al. |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. |
2016 |
Pharm Biol |
pmid:26731378
|
Çağan-Appak Y et al. |
Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children. |
2016 |
Turk. J. Pediatr. |
pmid:28276208
|
Thung I et al. |
Review article: the global emergence of Helicobacter pylori antibiotic resistance. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26694080
|
Villain J et al. |
Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models. |
2016 |
Ecotoxicol. Environ. Saf. |
pmid:26590695
|
Geng S et al. |
Clarithromycin ion pair in a liposomal membrane to improve its stability and reduce its irritation caused by intravenous administration. |
2016 |
Expert Opin Drug Deliv |
pmid:26588710
|
Eszik I et al. |
High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells. |
2016 |
J. Microbiol. Methods |
pmid:26578244
|
Jain SK et al. |
Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori. |
2016 |
AAPS PharmSciTech |
pmid:26566630
|
Di Giulio M et al. |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. |
2016 |
Scand. J. Gastroenterol. |
pmid:26554617
|
Djennane-Hadibi F et al. |
High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study. |
2016 |
Microb. Drug Resist. |
pmid:26554340
|
Chen CH et al. |
Mycobacterium abscessus complex bacteremia due to prostatitis after prostate biopsy. |
2016 |
Indian J Tuberc |
pmid:27998503
|
Gehlot V et al. |
Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India. |
2016 |
J Glob Antimicrob Resist |
pmid:27530837
|
Xuan SH et al. |
Detection of clarithromycin-resistant Helicobacter pylori in clinical specimens by molecular methods: A review. |
2016 |
J Glob Antimicrob Resist |
pmid:27436390
|
Siddiqui TR et al. |
Emerging trends of antimicrobial resistance in Helicobacter pylori isolates obtained from Pakistani patients: The need for consideration of amoxicillin and clarithromycin. |
2016 |
J Pak Med Assoc |
pmid:27339574
|
Lahmer T et al. |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS. |
2016 |
Mycopathologia |
pmid:26455910
|
Lee J et al. |
A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26441216
|
Shimizu T and Suzaki H |
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan. |
2016 |
Auris Nasus Larynx |
pmid:26441370
|
Apostolopoulos P et al. |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. |
2016 |
Scand. J. Gastroenterol. |
pmid:26435055
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|
Oh B et al. |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. |
2016 |
Helicobacter |
pmid:26395781
|
Lee J et al. |
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26373262
|